Citations

Clear

3942 citation(s) found for "To, Van".

Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors
Usset, Joseph , McGuire, Valerie , Sieh, Weiva , Webb, Penelope M. , Chang‐Claude, Jenny, Brinton, Louise A. , Cunningham, Julie M. , DeFazio, Anna , Edwards, Robert P., Gayther, Simon A. , Goodman, Marc T. , Høgdall, Estrid , Jensen, Allan , Johnatty, Sharon E., Lurie, Galina, Massuger, Leon F.A.G. , Menon, Usha , Moysich, Kirsten B. , Ness, Roberta B., Pike, Malcolm C. , Ramus, Susan J. , Rossing, Mary Anne, Rothstein, Joseph H. , Song, Honglin , Thompson, Pamela J., Berg, David J. Van Den, Vierkant, Robert A. , Wang‐Gohrke, Shan , Wentzensen, Nicolas , Whittemore, Alice S. , Wu, Anna H. , Pearce, Celeste Leigh, Schildkraut, Joellen M. , Goode, Ellen L. , Fazio, Anna de , Raghavan, Rama , Tyrer, Jonathan P. , Rudolph, Anja , Anton‐Culver, Hoda , Berchuck, Andrew , Doherty, Jennifer A. , Gentry‐Maharaj, Aleksandra , Kiemeney, Lambertus A. , Kjær, Susanne K. , Larson, Melissa C. , Modugno, Francesmary , Wilkens, Lynne R. , Yang, Hannah , Pharoah, Paul D.P. , Fridley, Brooke L. , Ramus, Susan J , Webb, Penelope M , Jensen, Allan , Vierkant, Robert A , Menon, Usha , Moysich, Kirsten , Sieh, Weiva , Høgdall, Estrid , Goodman, Marc T

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | March 14, 2016 | Volume: 25 | Issue: 5 | Pages: 780-790

10.1158/1055-9965.epi-15-1039 | PMID 26976855 Get It

Abstract Background: Many epithelial ovarian cancer (EOC) risk factors relate to hormone exposure and elevated estrogen levels are associated with obesity in postmenopausal women. Therefore, we hypothesized that gene–environment interactions related to hormone-related risk factors could differ between obese and non-obese women. Methods: We considered interactions between 11,441 SNPs within 80 candidate genes related to hormone biosynthesis and metabolism and insulin-like growth factors with six hormone-related factors (oral contraceptive use, parity, endometriosis, tubal ligation, hormone replacement therapy, and estrogen use) and assessed whether these interactions differed between obese and non-obese women. Interactions were assessed using logistic regression models and data from 14 case–control studies (6,247 cases; 10,379 controls). Histotype-specific analyses were also completed. Results: SNPs in the following candidate genes showed notable interaction: IGF1R (rs41497346, estrogen plus progesterone hormone therapy, histology = all, P = 4.9 × 10−6) and ESR1 (rs12661437, endometriosis, histology = all, P = 1.5 × 10−5). The most notable obesity–gene–hormone risk factor interaction was within INSR (rs113759408, parity, histology = endometrioid, P = 8.8 × 10−6). Conclusions: We have demonstrated the feasibility of assessing multifactor interactions in large genetic epidemiology studies. Follow-up studies are necessary to assess the robustness of our findings for ESR1, CYP11A1, IGF1R, CYP11B1, INSR, and IGFBP2. Future work is needed to develop powerful statistical methods able to detect these complex interactions. Impact: Assessment of multifactor interaction is feasible, and, here, suggests that the relationship between genetic variants within candidate genes and hormone-related risk factors may vary EOC susceptibility. Cancer Epidemiol Biomarkers Prev; 25(5); 780–90. ©2016 AACR.
Development and Validation of a Disease‐Specific Questionnaire to Assess Patient‐Reported Symptoms in Polycystic Liver Disease
Neijenhuis, Myrte K., Hogan, Marie C. , Kamath, Patrick S. , Wijnands, Titus F. M., Ouweland, Ralf C.P.M. van den, Edwards, Marie E., Sloan, Jeff A. , Kievit, Wietske , Drenth, Joost P.H. , Gevers, Tom J.G. , Hogan, Marie C , Drenth, Joost P H

Mayo Clinic

Hepatology | March 12, 2016 | Volume: 64 | Issue: 1 | Pages: 151-160

10.1002/hep.28545 | PMID 26970415 Get It

Treatment of polycystic liver disease (PLD) focuses on symptom improvement. Generic questionnaires lack sensitivity to capture PLD‐related symptoms, a prerequisite to determine effectiveness of therapy. We developed and validated a disease‐specific questionnaire that assesses symptoms in PLD (PLD‐Q). We identified 16 PLD‐related symptoms (total score 0‐100 points) by literature review and interviews with patients and clinicians. The developed PLD‐Q was validated in Dutch (n = 200) and United States (US; n = 203) PLD patients. We assessed the correlation of PLD‐Q total score with European Organization for Research and Treatment of Cancer (EORTC) symptom scale, global health visual analogue scale (VAS) of EQ‐5D, and liver volume. To test discriminative validity, we compared PLD‐Q total scores of patients with different PLD severity stages (Gigot classification) and PLD‐Q total scores of PLD patients with general controls and polycystic kidney disease patients without PLD. Reproducibility was tested by comparing original test scores with 2‐week retest scores. In total, 167 Dutch and 124 US patients returned the questionnaire. Correlation between PLD‐Q total score and EORTC symptom scale (The Netherlands [NL], r = 0.788; US, r = 0.811) and global health VAS (NL, r = −0.517; US, r = −0.593) was good. There was no correlation of PLD‐Q total score with liver volume (NL, r = 0.138; P = 0.236; US, r = 0.254; P = 0.052). Gigot type III individuals scored numerically higher than type II patients (NL, 46 vs. 40; P = 0.089; US, 48 vs. 36; P = 0.055). PLD patients scored higher on the PLD‐Q total score than general controls (NL, 42 vs. 17; US, 40 vs. 13 points) and polycystic kidney disease patients without PLD (22 points). Reproducibility of PLD‐Q was excellent (NL, r = 0.94; US, 0.96). Conclusion: PLD‐Q is a valid, reproducible, and sensitive disease‐specific questionnaire that can be used to assess PLD‐related symptoms in clinical care and future research. (Hepatology 2016;64:151–160)
High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
Howat, William , Daley, Frances , Zabaglo, Lila, McDuffus, Leigh‐Anne, Blows, Fiona M., Coulson, Penny , Ali, H. Raza , Benı́tez, Javier , Brenner, Hermann , Stegmaier, Christa, Mannermaa, Arto, Chang‐Claude, Jenny , Sinn, Hans‐Peter , Tollenaar, Rob A.�E.�M. , Devilee, Peter , Figueroa, Jonine D. , Sherman, Mark E., Lissowska, Jolanta , Hewitt, Stephen M. , Eccles, Diana , Hooning, Maartje J. , Deurzen, Carolien HM van, Investigators, kConFab, Bolla, Manjeet K. , Wang, Qin , Jones, Michael E. , Schoemaker, Minouk J. , Leeuwen, Flora E. van , Veer, Laura van’t, Swerdlow, Anthony J. , Orr, Nick , Dowsett, Mitch , Easton, Douglas F. , Schmidt, Marjanka K. , García‐Closas, Montserrat , Abubakar, Mustapha , Milne, Roger L. , Mannermaa, Arto, Rudolph, Anja , Couch, Fergus J. , Hollestelle, Antoinette , Martens, John W.M. , Deurzen, Carolien HM van, Broeks, Annegien , Pharoah, Paul D.P. , Eccles, Diana , Swerdlow, Anthony J , Lissowska, Jolanta , Sinn, Peter , Jones, Michael E , Brenner, Hermann , García-Closas, Montserrat , Schmidt, Marjanka K , Benitez, Javier , Figueroa, Jonine D , Devilee, Peter , Schoemaker, Minouk J , Orr, Nick

Mayo Clinic

The Journal of Pathology: Clinical Research | March 2, 2016 | Volume: 2 | Issue: 3 | Pages: 138-153

10.1002/cjp2.42 | PMID 27499923 Get It

AbstractAutomated methods are needed to facilitate high‐throughput and reproducible scoring of Ki67 and other markers in breast cancer tissue microarrays (TMAs) in large‐scale studies. To address this need, we developed an automated protocol for Ki67 scoring and evaluated its performance in studies from the Breast Cancer Association Consortium. We utilized 166 TMAs containing 16,953 tumour cores representing 9,059 breast cancer cases, from 13 studies, with information on other clinical and pathological characteristics. TMAs were stained for Ki67 using standard immunohistochemical procedures, and scanned and digitized using the Ariol system. An automated algorithm was developed for the scoring of Ki67, and scores were compared to computer assisted visual (CAV) scores in a subset of 15 TMAs in a training set. We also assessed the correlation between automated Ki67 scores and other clinical and pathological characteristics. Overall, we observed good discriminatory accuracy (AUC = 85%) and good agreement (kappa = 0.64) between the automated and CAV scoring methods in the training set. The performance of the automated method varied by TMA (kappa range= 0.37–0.87) and study (kappa range = 0.39–0.69). The automated method performed better in satisfactory cores (kappa = 0.68) than suboptimal (kappa = 0.51) cores (p‐value for comparison = 0.005); and among cores with higher total nuclei counted by the machine (4,000–4,500 cells: kappa = 0.78) than those with lower counts (50–500 cells: kappa = 0.41; p‐value = 0.010). Among the 9,059 cases in this study, the correlations between automated Ki67 and clinical and pathological characteristics were found to be in the expected directions. Our findings indicate that automated scoring of Ki67 can be an efficient method to obtain good quality data across large numbers of TMAs from multicentre studies. However, robust algorithm development and rigorous pre‐ and post‐analytical quality control procedures are necessary in order to ensure satisfactory performance.
Predictive value of symptoms and signs in ulnar neuropathy at the elbow
Rubin, Devon I., Dimberg, Elliot L., Mauricio, Elizabeth A. , Gerpen, Jay A. van, Whitlock, Julia B., Mauricio, Elizabeth, Whitlock, Julia, Mauricio, Elizabeth A.

Mayo Clinic

Muscle & Nerve | February 26, 2016 | Volume: 53 | Issue: 6 | Pages: 998-998

10.1002/mus.25086 | PMID 26917349 Get It

RNA‐seq analysis of clinical‐grade osteochondral allografts reveals activation of early response genes
Yang, Lin , Lewallen, Eric A. , Camilleri, Emily T. , Bonin, Carolina A. , Jones, Dakota L. , Dudakovic, Amel , Galeano‐Garces, Catalina , Wang, Wei , Karperien, Marcel , Larson, A. Noelle , Dahm, Diane L., Levy, Bruce A. , Smith, Jay , Ryssman, Daniel B., Im, Hee‐Jeong , Wijnen, André J. van , Riester, Scott M. , Krych, Aaron J. , Camilleri, Emily , Lin, Yang , Larson, Annalise N, van Wijnen, Andre J, Stuart, Michael J. , Westendorf, Jennifer J. , van Wijnen, Andre J , Krych, Aaron J , Larson, A Noelle , Camilleri, Emily

Mayo Clinic

Journal of Orthopaedic Research | February 25, 2016 | Volume: 34 | Issue: 11 | Pages: 1950-1959

10.1002/jor.23209 | PMID 26909883 Get It

ABSTRACTPreservation of osteochondral allografts used for transplantation is critical to ensure favorable outcomes for patients after surgical treatment of cartilage defects. To study the biological effects of protocols currently used for cartilage storage, we investigated differences in gene expression between stored allograft cartilage and fresh cartilage from living donors using high throughput molecular screening strategies. We applied next generation RNA sequencing (RNA‐seq) and real‐time reverse transcription quantitative polymerase chain reaction (RT‐qPCR) to assess genome‐wide differences in mRNA expression between stored allograft cartilage and fresh cartilage tissue from living donors. Gene ontology analysis was used to characterize biological pathways associated with differentially expressed genes. Our studies establish reduced levels of mRNAs encoding cartilage related extracellular matrix (ECM) proteins (i.e., COL1A1, COL2A1, COL10A1, ACAN, DCN, HAPLN1, TNC, and COMP) in stored cartilage. These changes occur concomitantly with increased expression of “early response genes” that encode transcription factors mediating stress/cytoprotective responses (i.e., EGR1, EGR2, EGR3, MYC, FOS, FOSB, FOSL1, FOSL2, JUN, JUNB, and JUND). The elevated expression of “early response genes” and reduced levels of ECM‐related mRNAs in stored cartilage allografts suggests that tissue viability may be maintained by a cytoprotective program that reduces cell metabolic activity. These findings have potential implications for future studies focused on quality assessment and clinical optimization of osteochondral allografts used for cartilage transplantation. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1950–1959, 2016.
Vascular Cell Senescence Contributes to Blood–Brain Barrier Breakdown
Yamazaki, Yu , Baker, Darren J. , Tachibana, Masaya , Deursen, Jan M. van , Brott, Thomas, Bu, Guojun , Kanekiyo, Takahisa , Liu, Chia‐Chen , van Deursen, Jan M, Bu, Guojun , Baker, Darren J , Yamazaki, Yu

Mayo Clinic

Stroke | February 17, 2016 | Volume: 47 | Issue: 4 | Pages: 1068-1077

10.1161/strokeaha.115.010835 | PMID 26883501 Get It

Background and Purpose— Age-related changes in the cerebrovasculature, including blood–brain barrier (BBB) disruption, are emerging as potential risks for diverse neurological conditions. Because the accumulation of senescent cells in tissues is increasingly recognized as a critical step leading to age-related organ dysfunction, we evaluated whether senescent vascular cells are associated with compromised BBB integrity. Methods— Effects of vascular cell senescence on tight junction and barrier integrity were studied using an in vitro BBB model, composed of endothelial cells, pericytes, and astrocytes. In addition, tight junction coverage in microvessels and BBB integrity in BubR1 hypomorphic (BubR1 H/H ) mice, which display senescence cell-dependent phenotypes, were examined. Results— When an in vitro BBB model was constructed with senescent endothelial cells and pericytes, tight junction structure and barrier integrity (evaluated by transendothelial electric resistance and tracer efflux assay using sodium fluorescein and Evans blue-albumin were significantly impaired. Endothelial cells and pericytes from BubR1 H/H mice had increased senescent-associated β-galactosidase activity and p16 INK4a expression, demonstrating an exacerbation of senescence. The coverage by tight junction proteins in the cortical microvessels were reduced in BubR1 H/H mice, consistent with a compromised BBB integrity from permeability assays. Importantly, the coverage of microvessels by end-feet of aquaporin 4–immunoreactive astrocytes was not altered in the cortex of the BubR1 H/H mice. Conclusions— Our results indicate that accumulation of senescent vascular cells is associated with compromised BBB integrity, providing insights into the mechanism of BBB disruption related to biological aging.
Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease
Smith, Charles D. , Johnson, Eleanor S. , Jicha, Gregory A. , Schmitt, Frederick A. , Nelson, Peter T. , Kryscio, Richard J. , Murphy, Ronan, Wellnitz, Clinton V., Eldik, Linda J. Van , Jicha, Gregory A

Mayo Clinic

Brain and Behavior | February 16, 2016 | Volume: 6 | Issue: 3 | Pages: No page available

10.1002/brb3.438 | PMID 26925303 Get It

AbstractBackground and purposeVascular dementia (VAD) is a complex diagnosis at times difficult to distinguish from Alzheimer's disease (AD). MRI scans often show white matter hyperintensities (WMH) in both conditions. WMH increase with age, and both VAD and AD are associated with aging, thus presenting an attribution conundrum. In this study, we sought to show whether the amount of WMH in deep white matter (dWMH), versus periventricular white matter (PVH), would aid in the distinction between VAD and AD, independent of age.MethodsBlinded semiquantitative ratings of WMH validated by objective quantitation of WMH volume from standardized MRI image acquisitions. PVH and dWMH were rated separately and independently by two different examiners using the Scheltens scale. Receiver operator characteristic (ROC) curves were generated using logistic regression to assess classification of VAD (13 patients) versus AD (129 patients). Clinical diagnoses were made in a specialty memory disorders clinic.ResultsUsing PVH rating alone, overall classification (area under the ROC curve, AUC) was 75%, due only to the difference in age between VAD and AD patients in our study and not PVH. In contrast, dWMH rating produced 86% classification accuracy with no independent contribution from age. A global Longstreth rating that combines dWMH and PVH gave an 88% AUC.ConclusionsIncreased dWMH indicate a higher likelihood of VAD versus AD. Assessment of dWMH on MRI scans using Scheltens and Longstreth scales may aid the clinician in distinguishing the two conditions.
Optimizing Thawed Plasma Inventories
Kuker, Kasey N., Badjie, Karafa S., Johnson, Pamela M. , Bundy, Kevin L., Buskirk, Camille M. van , Stubbs, R. James , Bundy, Kevin L.

Mayo Clinic

American Journal of Clinical Pathology | February 16, 2016 | Volume: 138 | Issue: suppl_1 | Pages: A255-A255

10.1093/ajcp/138.suppl1.237 Get It

A tardy tongue palsy
O’Gorman, Cullen , Lindell, E. Paul , Klaas, James P. , O'Gorman, Cullen M, Van Gompel, Jamie J, Gompel, Jamie J. Van , O'gorman, Cullen M

Mayo Clinic

Neurology Clinical Practice | February 15, 2016 | Volume: 6 | Issue: 1 | Pages: No page available

10.1212/cpj.0000000000000193 | PMID 29443268 Get It